Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-004819
Filing Date
2018-05-15
Accepted
2018-05-15 16:06:09
Documents
64
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rsls-20180331x10q.htm 10-Q 1038812
2 EX-31.1 rsls-20180331ex3115eeaae.htm EX-31.1 13649
3 EX-31.2 rsls-20180331ex31224cae3.htm EX-31.2 14882
4 EX-32.1 rsls-20180331ex321f9cf97.htm EX-32.1 11975
5 EX-32.2 rsls-20180331ex3229fbfa8.htm EX-32.2 12090
  Complete submission text file 0001558370-18-004819.txt   5362183

Data Files

Seq Description Document Type Size
6 EX-101.INS rsls-20180331.xml EX-101.INS 1197986
7 EX-101.SCH rsls-20180331.xsd EX-101.SCH 42268
8 EX-101.CAL rsls-20180331_cal.xml EX-101.CAL 52109
9 EX-101.DEF rsls-20180331_def.xml EX-101.DEF 170259
10 EX-101.LAB rsls-20180331_lab.xml EX-101.LAB 331623
11 EX-101.PRE rsls-20180331_pre.xml EX-101.PRE 292396
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 9494296680
ReShape Lifesciences Inc. (Filer) CIK: 0001371217 (see all company filings)

EIN.: 481293684 | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 001-33818 | Film No.: 18836386
SIC: 3845 Electromedical & Electrotherapeutic Apparatus